It’s September, and the chase for performance is on as investors flock into some of the hottest stocks around. We give you 17 that may have a monster final four months.
Biotech Stocks May Have Finally Been Unleashed Michael Kramer and the Clients of Mott Capital Own CELG Stocks continued to move higher, led by the Biotech’s, which were up by about 3 percent. There’s something we haven’t said in a long time. The highly anticipated speech regarding drug prices by the President didn’t seem to … Read more
Biotech and Tech Stocks Are Approaching Make Or Break Moments The stock market picked right up from where it left off last week, with the S&P 500 continuing to surging to 2,721 up about 1.1 percent today. Based on the charts, it seems like we have a pretty good shot of continuing to rise to somewhere between … Read more
Why Biotech Stocks Will Continue To Reach Record Heights Biotech stocks continue to rip higher, with the S&P Biotech ETF ($XBI) reaching a new record high, and the Nasdaq Biotech ETF ($IBB) quickly running to $122. The XBI is now up by over 12 percent on the year, while the IBB is up about 10 … Read more
Stock Market Sells Off As Biotech Gets Rocked, Again! Just more of the same isn’t? Gap up at the open, then a slow drag lower the rest of the day. I hate days were the market just gaps up, what is the point? It always just fills the gap. You must avoid opens like the one … Read more